Phibro Animal Health PAHC EMEA — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Phibro Animal Health in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phibro Animal Health's emea — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phibro Animal Health's EMEA — revenue?
- Phibro Animal Health (PAHC) reported EMEA — revenue of $44.47M in Q1 2026.
- How has Phibro Animal Health's EMEA — revenue changed year-over-year?
- Phibro Animal Health's EMEA — revenue increased by 14.3% year-over-year, from $38.91M to $44.47M.
- What is the long-term trend for Phibro Animal Health's EMEA — revenue?
- Over 4 years (2021 to 2025), Phibro Animal Health's EMEA — revenue has grown at a 8.9% compound annual growth rate (CAGR), from $114.13M to $160.23M.
- What does EMEA — revenue mean?
- This metric represents the total net sales generated from the sale of animal health and mineral nutrition products within the Europe, Middle East, and Africa (EMEA) geographic region. It reflects the company's ability to capture market share and drive demand for its specialized product portfolio across these diverse international markets. Tracking this revenue stream is essential for assessing the company's geographic diversification and the effectiveness of its regional sales strategies.